Hostname: page-component-cb9f654ff-mwwwr Total loading time: 0 Render date: 2025-08-20T19:10:33.339Z Has data issue: false hasContentIssue false
  • English
  • Français

When all else fails

A locally devised structured decision process for enforcing clozapine therapy

Published online by Cambridge University Press:  02 January 2018

Stephen Pereira ,
Dominic Beer  and
Carol Paton
Stephen Pereira*
Affiliation:
132/134 Powis Street, Woolwich, London SE18 6NL
*
∗ Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and method

A small minority of treatment-refractory patients who could benefit from treatment with clozapine, refuse to comply with blood tests or oral treatment. Treatment with clozapine can be enforced under the Mental Health Act.

Results

An aide memoire was developed locally to guide clinicians through the process of enforcing clozapine treatment.

Clinical implications

It is possible to enforce treatment with clozapine under the Mental Health Act and so offer a valuable treatment option.

Information

Type
Original Papers
Information
Psychiatric Bulletin , Volume 23 , Issue 11: The Journal of Trends in Psychiatric Practice , November 1999 , pp. 654 - 656
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 Royal College of Psychiatrists

References

Barnes, T. R. E., McEvedy, C. J. B. & Nelson, H. E. (1996) Management of treatment-resistant schizophrenia unresponsive to clozapine. British Journal of Psychiatry, 169 (suppl. 31), 31 40.Google Scholar
British National Formulary (1998) British National Formulary. Volume 36. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain.Google Scholar
Kane, J. M. (1992) Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. British Journal of Psychiatry, 160 (suppl. 17), 41 45.Google Scholar
Mental Health Act Commission (1993) Guidance on the administration of clozapine and other treatments requiring blood tests under the provision of Part TV of the Mental Health Act Practice Note 1. Nottingham: Mental Health Act Commission.Google Scholar
Mortimer, A. (1996) Using Clozaril under the Mental Health Act Clozaril Patient Monitoring Service Newsletter. Issue 14. Camberley: Sandoz Pharmaceuticals.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.